Veledimex

Veledimex; small-molecule activator of the RheoSwitch Therapeutic System · Alaunos Therapeutics

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Veledimex, covering 2022-06-24 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102 [Phase 1]

See pricing